- Home
- LWLG vs VXRT Comparison
LWLG vs VXRT Comparison
Compare LWLG & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LWLG
- VXRT
- Stock Information
- Founded
- LWLG 1991
- VXRT N/A
- Country
- LWLG United States
- VXRT United States
- Employees
- LWLG N/A
- VXRT N/A
- Industry
- LWLG Containers/Packaging
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LWLG Industrials
- VXRT Health Care
- Exchange
- LWLG Nasdaq
- VXRT Nasdaq
- Market Cap
- LWLG 126.0M
- VXRT 119.0M
- IPO Year
- LWLG N/A
- VXRT N/A
- Fundamental
- Price
- LWLG $1.24
- VXRT $0.46
- Analyst Decision
- LWLG
- VXRT Strong Buy
- Analyst Count
- LWLG 0
- VXRT 2
- Target Price
- LWLG N/A
- VXRT $3.00
- AVG Volume (30 Days)
- LWLG 1.9M
- VXRT 9.5M
- Earning Date
- LWLG 08-08-2025
- VXRT 08-07-2025
- Dividend Yield
- LWLG N/A
- VXRT N/A
- EPS Growth
- LWLG N/A
- VXRT N/A
- EPS
- LWLG N/A
- VXRT N/A
- Revenue
- LWLG $88,105.00
- VXRT $47,395,000.00
- Revenue This Year
- LWLG N/A
- VXRT N/A
- Revenue Next Year
- LWLG N/A
- VXRT N/A
- P/E Ratio
- LWLG N/A
- VXRT N/A
- Revenue Growth
- LWLG 24.23
- VXRT 433.43
- 52 Week Low
- LWLG $0.79
- VXRT $0.29
- 52 Week High
- LWLG $4.23
- VXRT $1.07
- Technical
- Relative Strength Index (RSI)
- LWLG 53.71
- VXRT 44.57
- Support Level
- LWLG $1.21
- VXRT $0.54
- Resistance Level
- LWLG $1.38
- VXRT $0.60
- Average True Range (ATR)
- LWLG 0.11
- VXRT 0.09
- MACD
- LWLG -0.01
- VXRT -0.02
- Stochastic Oscillator
- LWLG 28.95
- VXRT 6.92
About LWLG Lightwave Logic Inc.
Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.